WASHINGTON, Dec. 2, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today reported results in a Phase II clinical study of VQW-765,…
Maryland Manufacturing Extension Partnership joins City/County consortium to expand third Biotech Bootcamp in Frederick FREDERICK, MD. (PRWEB) DECEMBER 01, 2022 Following…